The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125877851 12587785 1 I 20160514 20160718 20160725 20160725 EXP FR-PFIZER INC-2016349255 PFIZER 64.00 YR F Y 0.00000 20160725 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125877851 12587785 1 PS Tazocilline PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) UNK Y 50750 INJECTION
125877851 12587785 2 SS VANCOMYCIN HCL VANCOMYCIN HYDROCHLORIDE 1 UNK Y 62911 INJECTION
125877851 12587785 3 SS METHOTREXATE. METHOTREXATE 1 Intrathecal ON DAY 4 Y 11719 SOLUTION FOR INJECTION
125877851 12587785 4 SS Triflucan FLUCONAZOLE 1 400 MG, 1X/DAY 19949 400 MG QD
125877851 12587785 5 SS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Intravenous (not otherwise specified) 1 MG ON DAY 6 AND DAY 13 Y 71484 1 MG
125877851 12587785 6 SS IDARUBICIN HCL IDARUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 10 MG, AT DAY 6 AND 7, THEN AT DAY 13 AND 14 Y 50661 10 MG
125877851 12587785 7 SS CASPOFUNGINE BASE CASPOFUNGIN 1 UNK Y 0
125877851 12587785 8 SS DEXAMETHASONE. DEXAMETHASONE 1 10 MG/M2, DAILY (15 MG) FROM DAY 1 TO DAY 7, THEN FROM DAY 13 TO DAY 16 Y 0 15 MG
125877851 12587785 9 SS MEROPENEM ANHYDROUS MEROPENEM ANHYDROUS 1 UNK Y 0
125877851 12587785 10 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 30 MG, 1X/DAY 0 30 MG QD
125877851 12587785 11 C AROMASINE EXEMESTANE 1 Oral 25 MG, 1X/DAY 0 25 MG FILM-COATED TABLET QD
125877851 12587785 12 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 15 MG, 1X/DAY 0 15 MG QD
125877851 12587785 13 C PROPRANOLOL PROPRANOLOLPROPRANOLOL HYDROCHLORIDE 1 Oral ONE THIRD OF 40 MG TABLET IN THE MORNING AND IN THE EVENING 0 TABLET
125877851 12587785 14 C THYROZOL METHIMAZOLE 1 20 MG, 1X/DAY 0 20 MG FILM-COATED TABLET QD
125877851 12587785 15 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 3X/WEEK 0 TABLET
125877851 12587785 16 C FASTURTEC RASBURICASE 1 0
125877851 12587785 17 C ZOVIRAX ACYCLOVIR 1 200 MG, 3X/DAY 0 200 MG TID
125877851 12587785 18 C INEXIUM /01479302/ ESOMEPRAZOLE MAGNESIUM 1 40 MG, DAILY 0 40 MG
125877851 12587785 19 C ZOPHREN /00955301/ ONDANSETRON 1 UNK, AS NEEDED 0
125877851 12587785 20 C PLITICAN ALIZAPRIDE HYDROCHLORIDE 1 UNK, AS NEEDED 0
125877851 12587785 21 C ACUPAN NEFOPAM HYDROCHLORIDE 1 6 DF, DAILY 0 6 DF
125877851 12587785 22 C ZARZIO FILGRASTIM 1 Intravenous (not otherwise specified) 30 DAILY 0
125877851 12587785 23 C ATARAX HYDROXYZINEHYDROXYZINE HYDROCHLORIDE 1 25 MG, DAILY 0 25 MG
125877851 12587785 24 C G2 2 3 L, DAILY 0 3 L
125877851 12587785 25 C ACTRAPID INSULIN HUMAN 1 Subcutaneous 0
125877851 12587785 26 C KCL POTASSIUM CHLORIDE 1 Intravenous (not otherwise specified) 6 G, OVER 6 HOURS 0 6 G
125877851 12587785 27 C OXYNORM OXYCODONE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125877851 12587785 1 Febrile bone marrow aplasia
125877851 12587785 3 Acute lymphocytic leukaemia
125877851 12587785 5 Acute lymphocytic leukaemia
125877851 12587785 6 Acute lymphocytic leukaemia
125877851 12587785 7 Candida infection
125877851 12587785 8 Acute lymphocytic leukaemia
125877851 12587785 11 Hormone therapy
125877851 12587785 16 Hyperuricaemia
125877851 12587785 19 Nausea
125877851 12587785 20 Nausea
125877851 12587785 27 Analgesic therapy

Outcome of event

Event ID CASEID OUTC COD
125877851 12587785 DE
125877851 12587785 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125877851 12587785 Acute kidney injury
125877851 12587785 Blood alkaline phosphatase increased
125877851 12587785 Blood bilirubin increased
125877851 12587785 Blood culture positive
125877851 12587785 Candida infection
125877851 12587785 Confusional state
125877851 12587785 Diarrhoea
125877851 12587785 Gamma-glutamyltransferase increased
125877851 12587785 Hepatosplenic candidiasis
125877851 12587785 Hypokalaemia
125877851 12587785 Nephrogenic diabetes insipidus
125877851 12587785 Systemic candida
125877851 12587785 Transaminases increased
125877851 12587785 Tumour lysis syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125877851 12587785 1 20160503 0
125877851 12587785 2 20160507 20160519 0
125877851 12587785 4 20160515 0
125877851 12587785 5 20160507 0
125877851 12587785 6 20160507 0
125877851 12587785 7 20160509 0
125877851 12587785 8 20160423 0
125877851 12587785 9 20160518 20160526 0
125877851 12587785 10 20160527 0